UBS downgrades CNR to Neutral; raises PT to $105
UBS downgraded CNR from Buy to Neutral and raised its price target to $105 from $101, according to Hammerstone MarketTalk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.